Title: Long-term antibody response after the third dose of the inactivated SARS-CoV-2 vaccine
in MASLD patients
Version: 6 Date: 02 Sep 2024
Reviewer's report:
Dear Editors,
Dear Authors,
The authors have provided adequate changes in order to make complex methodology and
extensive results easy to follow.  All the minor suggestions have been taken into account. As I
have stated previously, I believe the manuscript is suitable for publication.
Title: Long-term antibody response after the third dose of the inactivated SARS-CoV-2 vaccine
in MASLD patients
Version: 6 Date: 02 Sep 2024
Reviewer's report:
Dear Editors,
Dear Authors,
The authors have provided adequate changes in order to make complex methodology and
extensive results easy to follow.  All the minor suggestions have been taken into account. As I
have stated previously, I believe the manuscript is suitable for publication.
Please review this paper.
user
Title: Long-term antibody response after the third dose of the inactivated SARS-CoV-2 vaccine
in MASLD patients
Version: 6 Date: 02 Sep 2024
Reviewer's report:
Dear Editors,
Dear Authors,
The authors have provided adequate changes in order to make complex methodology and
extensive results easy to follow.  All the minor suggestions have been taken into account. As I
have stated previously, I believe the manuscript is suitable for publication.
assistant